Status:
UNKNOWN
Clinical Effectiveness of iReadMore for People With Alexia
Lead Sponsor:
University College, London
Collaborating Sponsors:
Medical Research Council
Conditions:
Stroke
Brain Injuries
Eligibility:
All Genders
18+ years
Brief Summary
iReadMore will provide an app-based therapy for people with pure or central alexia. This study aims to test the clinical effectiveness of iReadMore for improving reading accuracy and speed in real wo...
Detailed Description
iReadMore is a self-led therapy app for improving single word reading accuracy and speed in individuals with acquired reading impairments. iReadMore has been demonstrated to improve reading speed and ...
Eligibility Criteria
Inclusion
- Over 18 years old
- Diagnosed with stroke, dementia, brain injury or brain tumour
- Diagnosed or self-diagnosed with impaired reading ability
- Willing and able to give informed consent for participation in the study
Exclusion
- History of developmental reading or speech and language disability
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04849091
Start Date
March 15 2021
End Date
April 1 2024
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Neurology, University College London
London, United Kingdom, WC1N 3AR